Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. (Q46606214)
Jump to navigation
Jump to search
scientific article published on 14 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. |
scientific article published on 14 August 2007 |
Statements
1 reference
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. (English)
1 reference
Robert G Gish
1 reference
Anna S Lok
1 reference
Ting-Tsung Chang
1 reference
Robert A de Man
1 reference
Adrian Gadano
1 reference
José Sollano
1 reference
Kwang-Hyub Han
1 reference
You-Chen Chao
1 reference
Shou-Dong Lee
1 reference
Melissa Harris
1 reference
Joanna Yang
1 reference
Richard Colonno
1 reference
Helena Brett-Smith
1 reference
14 August 2007
1 reference
1 reference
133
1 reference
5
1 reference
1437-1444
1 reference